We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

221 hedge funds and large institutions have $674M invested in Ironwood Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 77 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

92,654% more call options, than puts

Call options by funds: $46.4M | Put options by funds: $50K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 226 → 221 (-5)

5.47% less ownership

Funds ownership: 107.8% → 102.34% (-5.5%)

10% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 77

11% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 44

40% less capital invested

Capital invested by funds: $1.12B → $674M (-$443M)

Holders
221
Holders Change
-5
Holders Change %
-2.21%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
39
Increased
69
Reduced
77
Closed
44
Calls
$46.4M
Puts
$50K
Net Calls
+$46.3M
Net Calls Change
-$27.1M

Top Buyers

1
Pacer Advisors
Pacer Advisors
Pennsylvania
+$12.8M
2
KCM
Kynam Capital Management
New Jersey
+$11M
3
SCM
Stonepine Capital Management
Oregon
+$5.12M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.23M
5
State Street
State Street
Massachusetts
+$3.64M

Top Sellers

1
BCM
Brown Capital Management
Maryland
-$16.8M
2
Man Group
Man Group
United Kingdom
-$11.2M
3
GT
Glenmede Trust
Pennsylvania
-$9.1M
4
JP Morgan Chase
JP Morgan Chase
New York
-$8.31M
5
First Eagle Investment Management
First Eagle Investment Management
New York
-$7.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$1.39M -$149K -27,736 -8%
Franklin Resources
52
Franklin Resources
California
$1.34M -$38.3K -7,127 -2%
Jane Street
53
Jane Street
New York
$1.33M +$882K +164,006 +103%
OAC
54
OMERS Administration Corp
Ontario, Canada
$1.32M -$68.8K -12,800 -4%
WCM
55
Wedge Capital Management
North Carolina
$1.3M +$1.69M +314,843 New
BCM
56
Bridgeway Capital Management
Texas
$1.28M – – –
JP Morgan Chase
57
JP Morgan Chase
New York
$1.26M -$8.31M -1,546,140 -83%
Public Sector Pension Investment Board (PSP Investments)
58
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.23M -$51.1K -9,500 -3%
Walleye Capital
59
Walleye Capital
New York
$1.15M +$1.09M +203,331 +264%
Swiss National Bank
60
Swiss National Bank
Switzerland
$1.14M – – –
UBS AM
61
UBS AM
Illinois
$1.11M -$209K -38,965 -13%
D.E. Shaw & Co
62
D.E. Shaw & Co
New York
$1.01M -$754K -140,268 -36%
Victory Capital Management
63
Victory Capital Management
Texas
$898K -$24.5K -4,564 -2%
WAM
64
Weiss Asset Management
Massachusetts
$893K +$1.17M +216,707 New
AIMCA
65
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$868K – – –
Dimensional Fund Advisors
66
Dimensional Fund Advisors
Texas
$858K -$28.7K -5,346 -3%
DMKJ
67
David M. Knott Jr
$853K -$876K -162,967 -44%
EMFAT
68
Emerald Mutual Fund Advisers Trust
Pennsylvania
$813K -$2.4M -446,757 -69%
Citigroup
69
Citigroup
New York
$767K +$8.09K +1,505 +0.8%
SSA
70
Schonfeld Strategic Advisors
New York
$748K -$889K -165,447 -48%
HWAM
71
Hennion & Walsh Asset Management
New Jersey
$704K +$221K +41,162 +32%
Fidelity Investments
72
Fidelity Investments
Massachusetts
$699K +$183K +34,089 +25%
HCA
73
Harbor Capital Advisors
Illinois
$692K +$302K +56,097 +50%
Macquarie Group
74
Macquarie Group
Australia
$689K – – –
AllianceBernstein
75
AllianceBernstein
Tennessee
$672K – – –
1 2
3
4 5

IRWD Hedge Fund Activity: Q3 2024 in Review

221 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2024, worth a combined $674M — down 40% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IRWD and 39 opened new positions — a net loss of 5 holders — while 77 trimmed existing stakes and 69 added.

The largest buyer was Pacer Advisors, adding an estimated $12.8M. The largest seller was Brown Capital Management, exiting entirely with an estimated $16.8M sold.

  • 221 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2024, down from 226 in Q2 2024.
  • Funds reported $674M of Ironwood Pharmaceuticals stock for Q3 2024, down 40% quarter-over-quarter.
  • 39 funds opened new Ironwood Pharmaceuticals positions in Q3 2024 and 44 closed out, a net change of -5 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2024 was Pacer Advisors, an estimated $12.8M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2024 was Brown Capital Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q3 2024.